Back to search

Germany· DE-A57-f3b5f7620697228e

Icatibant Zentiva

A icatibant product containing icatibant, registered in Germany by Zentiva Pharma Gmbh. The same ATC class is registered in 15 of our 19 countries.

ATC B06AC02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedIcatibant ZentivaATCB06AC02REGISTER NO.DE-A57-f3b5f762069722…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Icatibant is registered in 15 of 19 countries.

Countries holding a registration under ATC B06AC02 (icatibant), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose

Icatibant · ATC B06AC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Icatibant
Manufacturer
Zentiva Pharma Gmbh
Country
Germany (DE)
ATC code
B06AC02
ATC class
Icatibant
Defined daily dose
30 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for icatibant.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Icatibant · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • CaptoprilC09AA01moderate
  • EnalaprilC09AA02moderate
  • LisinoprilC09AA03moderate
  • PerindoprilC09AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Icatibant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All icatibant products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Icatibant Hikma, Icatibant Ratiopharm®
  • Belgium · Icatibant Hikma Farmacêutica (Portugal) S.A., Icatibant Teva
  • Bulgaria · Icatibant Sandoz
  • Czechia · Icatibant Fresenius, Icatibant Universal Farma
  • Denmark · Icatibant "viatris", Icatibant Adalvo
  • Estonia · Icatibant Auxilia, Icatibant Fresenius
  • Spain · Icatibanto Cipla, Icatibanto Exeltis
  • Finland · Icatibant Avansor, Icatibant Glenmark
  • France · Icatibant Amarox, Icatibant Fresenius
  • United Kingdom (Northern Ireland) · Icatibant Amarox, Icatibant Fresenius Kabi Limited
  • Croatia · Ikatibant Alpha-Medical, Ikatibant Fresenius
  • Hungary · Icatibant Fresenius, Icatibant Stada
  • Iceland · Firazyr, Icatibant Accord
  • Italy · Icatibant, Icatibant Amarox
  • Liechtenstein · Firazyr, Icatibant Accord
  • Lithuania · Icatibant Fresenius, Idanuz
  • Latvia · Idanuz
  • Malta · Icatibant Newbury, Idisan
  • Netherlands · Icatibant Ethypharm, Icatibant Glenmark
  • Norway · Firazyr, Icatibant
  • Poland · Icatibant Universal Farma, Idanuz
  • Portugal · Icatibant Fresenius, Icatibant Hikma Farmacêutica (Portugal) S.A.
  • Romania · Icatibant Stada, Icatibant Universal Farma
  • Sweden · Icatibant Avansor, Icatibant Glenmark
  • Slovakia · Icatibant Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec3e805a-bb9b-43d5-b126-b59ee53e40a8
GET /v1/drugs/ec3e805a-bb9b-43d5-b126-b59ee53e40a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Subcutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Icatibant",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about icatibant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.